O

OrganoTherapeutics

4 employees

OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Biopharma
Life Science

Date founded

2019

Funding rounds raised

O

OrganoTherapeutics raised undisclosed on July 26, 2023

Investors: KHANU Management GmbH

O

OrganoTherapeutics raised undisclosed on October 21, 2020

Investors: Creative Destruction Lab

FAQ